17-41055153-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_033032.3(KRTAP2-2):​c.59G>T​(p.Cys20Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 19)

Consequence

KRTAP2-2
NM_033032.3 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.146
Variant links:
Genes affected
KRTAP2-2 (HGNC:18905): (keratin associated protein 2-2) Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15950239).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KRTAP2-2NM_033032.3 linkc.59G>T p.Cys20Phe missense_variant Exon 1 of 1 ENST00000398477.1 NP_149021.2 Q9BYT5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KRTAP2-2ENST00000398477.1 linkc.59G>T p.Cys20Phe missense_variant Exon 1 of 1 6 NM_033032.3 ENSP00000381494.1 Q9BYT5

Frequencies

GnomAD3 genomes
Cov.:
19
GnomAD4 exome
Cov.:
21
GnomAD4 genome
Cov.:
19

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 06, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.59G>T (p.C20F) alteration is located in exon 1 (coding exon 1) of the KRTAP2-2 gene. This alteration results from a G to T substitution at nucleotide position 59, causing the cysteine (C) at amino acid position 20 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
16
DANN
Benign
0.95
DEOGEN2
Benign
0.049
T;.
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.44
T;T
M_CAP
Benign
0.0045
T
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
3.1
M;.
PrimateAI
Uncertain
0.59
T
PROVEAN
Pathogenic
-7.6
D;D
REVEL
Benign
0.14
Sift
Benign
0.087
T;T
Sift4G
Uncertain
0.020
D;D
Vest4
0.18
MutPred
0.45
Gain of loop (P = 0.3485);Gain of loop (P = 0.3485);
MVP
0.46
ClinPred
0.69
D
GERP RS
-2.4
Varity_R
0.33
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-39211405; API